about
Neural Control of Energy ExpenditureThe Neuromuscular Junction: Aging at the Crossroad between Nerves and MuscleBlood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral SclerosisA randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosisAcyl coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity.Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?Current pathways for epidemiological research in amyotrophic lateral sclerosis.Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?The secreted MSP domain of C. elegans VAPB homolog VPR-1 patterns the adult striated muscle mitochondrial reticulum via SMN-1Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosisBody mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosisMapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialDihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisElevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis.Adenosine monophosphate-activated protein kinase activation enhances embryonic neural stem cell apoptosis in a mouse model of amyotrophic lateral sclerosis.Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury.Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral SclerosisRiluzole increases the rate of glucose transport in L6 myotubes and NSC-34 motor neuron-like cells via AMPK pathway activation.Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans.Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functionsAssociation analysis of four candidate genetic variants with sporadic amyotrophic lateral sclerosis in a Chinese population.Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.Immune aging, dysmetabolism, and inflammation in neurological diseases.Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosisTriheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral SclerosisCharacterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-IIIThe longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosisPrediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish modelPremorbid body mass index and risk of amyotrophic lateral sclerosis
P2860
Q26853654-DE6D5E40-772E-4BCC-AC77-53709457348AQ27030836-0A5FA968-4B01-4190-A402-9B7E8814B422Q28546154-3CFBC88D-297B-433A-B42A-16BEBEE97AFAQ28728672-D519384B-0061-4CEE-B753-835C3D2F3335Q30447826-36518F9D-3B0B-403D-8529-CE9308FF602DQ30552760-A701D4E2-BF1F-4DFC-BE16-61BA06E1E717Q30659873-674A931F-CFFD-4F73-89A8-9337EF0139DAQ33582007-7F7BFFFD-A507-4822-8AC5-EB53CABC8A7EQ33697436-680E7EE3-6234-4260-822C-007F24652684Q33729341-4D727A11-A843-4EAF-A296-E3ADADA3D257Q33767845-968D8D6C-013B-460B-AF24-3B2277307187Q33830454-0FFD5967-CD94-452D-811C-A0D9529B793EQ33854270-5DB4BCD1-913A-4655-A06D-6925A46A17F4Q34074537-9483F0DC-E62C-4CCD-AE98-27A900EC7B60Q34187004-8F2E8957-D946-4656-917F-C0B0F8BDF434Q34235637-85562B0C-9187-498B-92BE-8025CCD0837DQ34251334-00F7E16E-41EC-43DE-BBCE-A0DB157C00D4Q34273954-FF8C270D-C3FF-419B-A95B-679FA05CCCB8Q34344992-B0CE1C51-F50B-4691-AB1E-2CBD34F654C7Q34425189-3948B235-5E22-4104-AD94-6E4CF895082EQ34546198-7359A0A8-3974-44C5-86AC-5117D444B383Q34778610-40E40D21-F216-475B-ABB4-04BC3B3A83E1Q34797530-D0502330-90AD-491C-B383-FCE3CF13C652Q34802341-180E49C9-C3EF-4367-BF80-4E53E70E5B80Q34815254-6DEA77CB-3BC0-4337-8150-1521565EE4C5Q34979308-8D3F7711-5C13-4260-8439-876E3E5AECF4Q34988024-9A5155BE-2765-4D0C-9B68-BA78976DC933Q35086167-9B1B5901-7947-4FCC-89D1-041BF0487626Q35086781-3094CF9D-9A3A-4F00-B611-1E01D82872CBQ35111080-08976C89-781D-4148-90DF-CF1BE928FCC5Q35677347-47A13B39-B023-422F-9CE1-4EB8CFE93550Q35800499-84DA9DE5-D5B9-41EB-A2B1-EB6FBDB119CCQ35822554-E64F4B02-E0B6-40C0-8B18-680068E446D5Q36114275-B2F3209E-BDCD-4351-ABC9-01C1DE39B8A6Q36299228-7402AEDD-98F7-44B9-907E-18A4B3D021E4Q36302226-F8B83FAB-3814-4158-BB88-0C7CD0B112A0Q36482355-75ACB3F0-555F-4949-964C-8DE52C80C23FQ36687156-AFB0C28B-F67F-4BAE-9AF2-A1B800669BEBQ36718274-BDEEFBA2-25F1-4387-87E1-4CE864BFD8F1Q36737158-2C9A1B7F-CD94-4A5C-B785-9D4FD65CB2B6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Energy metabolism in amyotrophic lateral sclerosis.
@en
Energy metabolism in amyotrophic lateral sclerosis.
@nl
type
label
Energy metabolism in amyotrophic lateral sclerosis.
@en
Energy metabolism in amyotrophic lateral sclerosis.
@nl
prefLabel
Energy metabolism in amyotrophic lateral sclerosis.
@en
Energy metabolism in amyotrophic lateral sclerosis.
@nl
P1433
P1476
Energy metabolism in amyotrophic lateral sclerosis.
@en
P2093
Jean-Philippe Loeffler
Luc Dupuis
P356
10.1016/S1474-4422(10)70224-6
P577
2010-10-27T00:00:00Z